Kate Casey

The Leeds Gamma Knife Centre

Previous Advanced Nurse Practitioner employed as the Gamma Knife and Radiotherapy Services Manager at the Leeds Gamma Knife Centre in 2010. I lead a team of 5 radiographers treating 250 patients a year. We have a NHSE contract to deliver adult and paediatric radiosurgery. I have attended numerous Stereotactic Radiosurgery meetings around the world to enhance my knowledge and enable me to develop the service.

dont miss

ICON LEKSELL GAMMA KNIFE STEREOTACTIC RADIOSURGERY

Icon enables Leeds Gamma Knife Centre’s team of neurosurgeons and neuro-oncologists to deliver treatment to tumours close to critical structures and a larger volume than the Perfexion model without compromising the dose control, precision or conformity. This seminar demonstrates how Icon delivers flexibility and increased clinical versatility with the ability to choose the level of immobilisation a patient requires between fixed frame and mask with CBCT and infrared intra-fraction monitoring.

EVEN MORE SEMINARS

  • Dr Khurum Khan: Speaking at the Oncology Convention

    Dr Khurum Khan
    University College London Hospitals

    Translational research in GI Oncology- how to make progress?

  • Professor Anthony Howell: Speaking at the Oncology Convention

    Professor Anthony Howell
    The University of Manchester / The Christie NHS Foundation Trust

    Improving risk estimation of breast cancer

  • Malcolm Wilson: Speaking at the Oncology Convention

    Malcolm Wilson
    The Colorectal & Peritoneal Oncology Centre, The Christie Hospital NHS Foundation Trust, Manchester

    Cytoreduction and HIPEC in the treatment of peritoneal disease from appendiceal and colorectal tumours

  • Dr Catherine Coyle: Speaking at the Oncology Convention

    Dr Catherine Coyle
    Christie Hospital NHS Foundation Trust

    Prostate Cancer- the non surgical oncologists view

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations